First-time surgical aortic valve replacement: nationwide trends and outcomes from The Netherlands Heart Registration.

Edgar J DaeterHector Willem Livius de BeaufortMaaike M RoefsWim Jan P van BovenDennis van VeghelNiels P van der Kaaijnull null

Published in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2024)

Between 2007 and 2018, age and risk profile of patients undergoing SAVR decreased, especially for patients treated with a biological prosthesis. The 120-day mortality decreased over time. Patients undergoing SAVR nowadays have a risk of 120-day mortality of <1% and 10-year freedom from valve-related reintervention of >95%.

Keyphrases

patients undergoing
aortic valve replacement
aortic valve
aortic stenosis
transcatheter aortic valve implantation
cardiovascular events
transcatheter aortic valve replacement
ejection fraction
heart failure
risk factors
mitral valve
coronary artery disease
atrial fibrillation
cardiovascular disease
type diabetes